Table 1.
Patient Demographics
| HM (n = 908) | Conventional (n = 431) | P value | |
|---|---|---|---|
| Age at enrolment (years) | 63.3 ± 12.8 | 64.0 ± 12.1 | 0.365 |
| Gender: male | 72.0% | 73.1% | 0.695 |
| ICD indications: prophylactic | 72.2% | 73.8% | 0.599 |
| LVEF % (within last 12 months) | 29.0 ± 10.7 | 28.5 ± 9.8 | 0.497 |
| Patients with CAD | 64.8% | 71.7% | 0.013 |
| Dual-chamber implants | 57.8% | 56.6% | 0.679 |
| β-Blockers | 79.6% | 76.3% | 0.176 |
| ACE | 42.8% | 46.4% | 0.239 |
| ARBs | 7.7% | 9.5% | 0.289 |
P: statistical comparison between study arms.
LVEF, left ventricular ejection fraction; CAD, coronary artery disease; ACE, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker.